Biota Pharmaceuticals, Inc. (NASDAQ:NABI.DL)

CAPS Rating: No stars

The Company leverage its experience and knowledge in powering the human immune system to develop and market products that target serious medical conditions in the areas of transplantation, infectious disease and hematology/oncology.


Player Avatar tharlow (72.93) Submitted: 8/18/2007 5:18:49 AM : Outperform Start Price: $3.55 NABI.DL Score: -1.11

Could be huge.

Featured Broker Partners